| |  Online-Ressource |
|---|
| Verfasst von: | Górska, Aga [VerfasserIn]  |
|---|
| | Sandmann, Clara [VerfasserIn] |
|---|
| | Riechert, Eva [VerfasserIn] |
|---|
| | Sandmann, Christoph [VerfasserIn] |
|---|
| | Malovrh, Ellen [VerfasserIn] |
|---|
| | Varma, Eshita [VerfasserIn] |
|---|
| | Kmietczyk, Vivien [VerfasserIn] |
|---|
| | Ölschläger, Julie [VerfasserIn] |
|---|
| | Jürgensen, Lonny [VerfasserIn] |
|---|
| | Kamuf-Schenk, Verena [VerfasserIn] |
|---|
| | Stroh, Claudia [VerfasserIn] |
|---|
| | Furkel, Jennifer [VerfasserIn] |
|---|
| | Konstandin, Mathias [VerfasserIn] |
|---|
| | Sticht, Carsten [VerfasserIn] |
|---|
| | Boileau, Etienne [VerfasserIn] |
|---|
| | Dieterich, Christoph [VerfasserIn] |
|---|
| | Frey, Norbert [VerfasserIn] |
|---|
| | Katus, Hugo [VerfasserIn] |
|---|
| | Doroudgar, Shirin [VerfasserIn] |
|---|
| | Völkers, Mirko [VerfasserIn] |
|---|
| Titel: | Muscle-specific Cand2 is translationally upregulated by mTORC1 and promotes adverse cardiac remodeling |
|---|
| Verf.angabe: | Agnieszka A Górska, Clara Sandmann, Eva Riechert, Christoph Hofmann, Ellen Malovrh, Eshita Varma, Vivien Kmietczyk, Julie Ölschläger, Lonny Jürgensen, Verena Kamuf-Schenk, Claudia Stroh, Jennifer Furkel, Mathias H Konstandin, Carsten Sticht, Etienne Boileau, Christoph Dieterich, Norbert Frey, Hugo A Katus, Shirin Doroudgar & Mirko Völkers |
|---|
| E-Jahr: | 2021 |
|---|
| Jahr: | 4 October 2021 |
|---|
| Umfang: | 19 S. |
|---|
| Fussnoten: | Gesehen am 22.06.2023 |
|---|
| Titel Quelle: | Enthalten in: European Molecular Biology OrganizationEMBO reports |
|---|
| Ort Quelle: | [London] : Nature Publishing Group UK, 2000 |
|---|
| Jahr Quelle: | 2021 |
|---|
| Band/Heft Quelle: | 22(2021), 12, Artikel-ID e52170, Seite 1-19 |
|---|
| ISSN Quelle: | 1469-3178 |
|---|
| Abstract: | Abstract The mechanistic target of rapamycin (mTOR) promotes pathological remodeling in the heart by activating ribosomal biogenesis and mRNA translation. Inhibition of mTOR in cardiomyocytes is protective; however, a detailed role of mTOR in translational regulation of specific mRNA networks in the diseased heart is unknown. We performed cardiomyocyte genome-wide sequencing to define mTOR-dependent gene expression control at the level of mRNA translation. We identify the muscle-specific protein Cullin-associated NEDD8-dissociated protein 2 (Cand2) as a translationally upregulated gene, dependent on the activity of mTOR. Deletion of Cand2 protects the myocardium against pathological remodeling. Mechanistically, we show that Cand2 links mTOR signaling to pathological cell growth by increasing Grk5 protein expression. Our data suggest that cell-type-specific targeting of mTOR might have therapeutic value against pathological cardiac remodeling. |
|---|
| DOI: | doi:10.15252/embr.202052170 |
|---|
| URL: | kostenfrei: Volltext: https://doi.org/10.15252/embr.202052170 |
|---|
| | kostenfrei: Volltext: https://www.embopress.org/doi/full/10.15252/embr.202052170 |
|---|
| | DOI: https://doi.org/10.15252/embr.202052170 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Cand2 |
|---|
| | cardiac |
|---|
| | hypertrophy |
|---|
| | mTOR |
|---|
| K10plus-PPN: | 1850820937 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
| |
|
|---|
| | |
|---|
| Lokale URL UB: |  Zum Volltext |
|---|
Muscle-specific Cand2 is translationally upregulated by mTORC1 and promotes adverse cardiac remodeling / Górska, Aga [VerfasserIn]; 4 October 2021 (Online-Ressource)
